7498 Results (Page 206 of 300)
Pharmaceuticals Markets Research Reports
Turkey Diabetes Therapeutics Market Analysis
Turkey's diabetes therapeutics market is expected to witness growth from $1.1 Bn in 2022 to $2.5 Bn in 2030 with a CAGR of 10.2% for the forecasted year 2022-30. The rising awareness about diabetes and the supportive government policies to promote diabetes in Turkey are the major market drivers. The Turkey diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Nobel İlaç, Koçak Farma, and GlaxoSmithKline are the major players in the Turkey diabetes therapeutics market.
Turkey Diabetes Drugs Market Analysis
This report presents a strategic analysis of the Turkey Diabetes Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Turkey Diabetes Drugs Market, offering unmatched value, accuracy, and expert insights.
Turkey Advanced Therapy Medicinal Products (ATMPs) Market Analysis
This report presents a strategic analysis of Turkey's Advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about Turkey's Advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy, and expert insights.
Thailand Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Thailand Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand Retail Pharmacy Market, offering unmatched value, accuracy, and expert insights.
Thailand Radiotherapy Market Analysis
By 2030, it is anticipated that the Thailand Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Thailand is dominated by a few domestic players such as Bangkok Medical Supply, OTO-Medical, and Thai Radiology Equipment. The radiotherapy market in Thailand is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Thailand Radiotherapy is increasing due to the rise in cancer cases in the country.
Vietnam Addiction Therapeutics Market Analysis
Vietnam addiction therapeutics market was valued at $51 Mn in 2022 and is estimated to reach $88 Mn in 2030, exhibiting a CAGR of 7.13% during the forecast period. The growth of programs aimed at increasing drug knowledge and avoiding substance usage is one of the main drivers of the addiction therapeutics market. Dominant key players operating in the market include Indivior, Alkermes, Reckitt Benckiser, Otsuka Pharmaceutical Co., Pfizer, Mallinckrodt, Purdue Pharma L.P., GlaxoSmithKline, Teva Pharmaceutical and Novartis
UK Addiction Therapeutics Market Analysis
UK addiction therapeutics market was valued at $263 Mn in 2022 and is estimated to reach $385 Mn in 2030, exhibiting a CAGR of 4.9% during the forecast period. The addiction treatment industry is expanding due to a greater understanding and acceptance of substance use disorders as significant public health concerns. Major market players are Indivior, Reckitt Benckiser Pharmaceuticals, Camurus AB, Molteni Farmaceutici, Ethypharm, Martindale Pharma, Accord Healthcare, Sun Pharmaceutical Industries, Wockhardt UK and Martindale Pharma
UAE Addiction Therapeutics Market Analysis
UAE addiction therapeutics market was valued at $51 Mn in 2022 and is estimated to reach $93 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The rise in mental health awareness and awareness about addiction treatments through government encouragement and support has increased investments in addiction therapeutics infrastructure which has in turn reduced the social stigma associated with it. These changes in environment have led to an increase in the addiction treatment drug market in the UAE. Some major key players in UAE addiction therapeutics are Viatris, Sahara Pharmaceutical, AbbVie, Pfizer, Indivior, Reckitt Benckiser Pharmaceuticals, Mundipharma, Teva Pharmaceutical, Alkermes and Hikma
Spain Addiction Therapeutics Market Analysis
Spain addiction therapeutics market was valued at $195 Mn in 2022 and is estimated to reach $308 Mn in 2030, exhibiting a CAGR of 5.9% during the forecast period. The market for addiction treatment is growing as a result of the growing understanding and recognition of substance use disorders as serious public health issues. Major market players are Indivior, Reckitt Benckiser Pharmaceuticals, Teva Pharmaceutical Industries, Mundipharma, Camurus AB, Grunenthal, Ethypharm, Molteni Farmaceutici, Lacer and Asofarma
South Africa Addiction Therapeutics Market Analysis
South Africa addiction therapeutics market was valued at $66 Mn in 2022 and is estimated to reach $123 Mn in 2030, exhibiting a CAGR of 8.13% during the forecast period. Public awareness has improved as a result of the anti-drug campaigns and encouraging government measures, and this has significantly expanded the addiction therapeutics market. Some of the leading companies in the market are Aspen Pharmacare, Adcock Ingram, Mylan Pharmaceuticals, Teva Pharmaceuticals, AbbVie, Reckitt Benckiser, Sun Pharma Industries, Cipla, Alkermes and Lupin Pharmaceuticals
Singapore Addiction Therapeutics Market Analysis
Singapore addiction therapeutics market was valued at $12 Mn in 2022 and is estimated to reach $22 Mn in 2030, exhibiting a CAGR of 7.5% during the forecast period. One of the main factors driving the addiction therapeutics market is the increase in drug awareness and prevention activities. Leading key players functioning in the market include Indivior, Alkermes, Reckitt Benckiser Pharmaceuticals, Otsuka Pharmaceutical, Pfizer, Mallinckrodt, Purdue Pharma L.P., GlaxoSmithKline, Teva Pharmaceutical, and Novartis AG.
Thailand Oncology Drugs Market Analysis
By 2030, it is anticipated that the Thailand oncology drugs market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The oncology drugs market in Thailand is dominated by a few domestic pharmaceutical companies such as Siam Bioscience, GPO, and Mega Lifesciences. The oncology market in Thailand is segmented into different therapeutic areas and different treatment types. The major factors affecting the Thailand oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of Thailand.
Saudi Arabia Addiction Therapeutics Market Analysis
Saudi Arabia addiction therapeutics market was valued at $172 Mn in 2022 and is estimated to reach $327 Mn in 2030, exhibiting a CAGR of 8.4% during the forecast period. The market is growing as the government is committed to addressing substance abuse problems by increasing mental health awareness and accessibility and improving access to addiction treatment facilities. The key players in addiction therapeutics market are Eradah (Al Amal) Mental Health Complex, Taif Mental Health Hospital, KAAUH developmental Hospital, Pfizer, Novartis, GSK, Johns Hopkins Aramco Healthcare Dhahran, Dr. Sulaiman Al-Habib Medical Group, AbbVie and Saudi German Hospitals Group
Thailand HIV Drugs Market Analysis
This report presents a strategic analysis of the Thailand HIV Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand HIV Drugs Market, offering unmatched value, accuracy, and expert insights.
Philippines Addiction Therapeutics Market Analysis
Philippines addiction therapeutics market was valued at $22 Mn in 2022 and is estimated to reach $39 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period. The market for addiction therapies has expanded significantly as a result of increased awareness of mental health issues, particularly drug addiction and misuse. The top pharmaceutical firms in the market for addiction therapeutics include United Laboratories, Pfizer, GlaxoSmithKline, AstraZeneca, Merck, Boehringer Ingelheim, Sanofi, Bayer, Abbott, Pharmaceutical and Healthcare Association of Philippines (PHAP).
Mexico Addiction Therapeutics Market Analysis
Mexico addiction therapeutics market was valued at $152 Mn in 2022 and is estimated to reach $263 Mn in 2030, exhibiting a CAGR of 7.15% during the forecast period. The development of the addiction treatment sector has been fuelled by increased public awareness brought about by anti-drug campaigns and encouraging government initiatives. Major players in the market, including Pfizer, Johnson & Johnson, Novartis, Bristol Myers Squibb, Merck, GlaxoSmithKline, Sanofi, AbbVie, Eli Lilly and Company, and Boehringer Ingelheim, are driving innovations in this field
Thailand Diabetes Therapeutics Market Analysis
Thailand's diabetes therapeutics market is expected to grow from $173 Mn in 2022 to $371 Mn in 2030 with a CAGR of 10.04% for the forecasted year 2022-30. Government policies promoting the awareness of diabetes and increased healthcare spending in Thailand have resulted in the expansion of the market. The Thailand diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Zuellig Pharma, Malachi, and Novartis are the major players in the Thailand diabetes therapeutics market.
Thailand Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Thailand Dermatology drugs market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The market is primarily dominated by local players such as Siam Pharmaceuticals, Thai Nakorn Patana, and Bangkok Dusit Medical Services. The market is driven by the prevalence of dermatology conditions, awareness about dermatological health, and medical tourism. The dermatology drug market in Thailand is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Thailand Dermatological Therapeutics Market Analysis
This report presents a strategic analysis of the Thailand Dermatological Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand Dermatological Therapeutics Market, offering unmatched value, accuracy, and expert insights.
Thailand Depression Therapeutics Market Analysis
This report presents a strategic analysis of the Thailand Depression Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Depression Therapeutics Market, offering unmatched value, accuracy and expert insights.
Malaysia Addiction Therapeutics Market Analysis
Malaysia addiction therapeutics market was valued at $16 Mn in 2022 and is estimated to reach $28 Mn in 2030, exhibiting a CAGR of 7.1% during the forecast period. The growing knowledge and understanding of mental health disorders, including substance abuse and addiction, has led to a major growth in the market for addiction therapeutics. The leading pharmaceutical companies in the addiction therapeutics market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, Merck, Bayer, Abbott, Johnson & Johnson, and Boehringer Ingelheim.
Kenya Addiction Therapeutics Market Analysis
Kenya addiction therapeutics market was valued at $7 Mn in 2022 and is estimated to reach $13 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The anti-drug campaigns and supportive government initiatives have increased public awareness, which has led to a notable expansion of the addiction therapeutic industry. AbbVie, Indivior, Reckitt Benckiser Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Glenmark Pharmaceuticals, Alkermes, Lupin Pharmaceuticals, and Cipla are some of the leading companies operating in the market
Japan Addiction Therapeutics Market Analysis
Japan addiction therapeutics market was valued at $628 Mn in 2022 and is estimated to reach $1111 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period. The increasing awareness and recognition of mental health issues, such as substance abuse and addiction, has led to a sharp increase in the market for addiction therapies. A few prominent entities in the addiction therapeutics industry comprise Takeda Pharmaceutical Company, Astellas Pharma Inc., Daiichi Sankyo Company, Eisai Co., Otsuka Pharmaceutical Co., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co., Chugai Pharmaceutical Co., Kyowa Kirin Co., and Sumitomo Dainippon Pharma
Indonesia Addiction Therapeutics Market Analysis
Indonesia addiction therapeutics market was valued at $61 Mn in 2022 and is estimated to reach $103 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period. The market for addiction therapies has grown rapidly due to the growing knowledge and identification of mental health concerns, including substance abuse and addiction. Some of the leading players operating in the market include Kalbe Farma, PT Sanbe Farma, PT Tempo Scan Pacific Tbk, PT Dexa Medica, Combiphar, PT Phapros Tbk, Abbott, Pfizer, Novartis AG and GSK.
Germany Addiction Therapeutics Market Analysis
Germany addiction therapeutics market was valued at $370 Mn in 2022 and is estimated to reach $550 Mn in 2030, exhibiting a CAGR of 5.1% during the forecast period. The market for addiction treatment is growing as a result of the growing understanding and recognition of substance use disorders as serious public health issues. Indivior, Mundipharma, Reckitt Benckiser Pharmaceuticals, Lundbeck, Sun Pharmaceutical Industries, Sanofi, Pfizer, GlaxoSmithKline (GSK), Novartis, and AstraZeneca are some of the major market players
